Dr. Shimon Yanowitz
Dr. Shimon Yanowitz is an Israeli electronics and engineering researcher who attracted significant attention in the independent scientific community from 2021 onwards for conducting a series of laboratory tests on COVID-19 vaccine vials. Drawing on his background in electrical engineering and applied physics, Yanowitz approached the question of vaccine composition from a technical rather than a purely biological standpoint — examining whether the contents of injection vials exhibited properties consistent with their declared ingredients, or whether anomalous material signatures pointed to something more complex.
His work became widely shared across platforms frequented by researchers investigating Graphene Oxide, Self-Assembling Nanostructures, and the broader hypothesis of technology-based components embedded within COVID-19 vaccine formulations. Yanowitz has been cited alongside a small but growing international cohort of independent scientists conducting similar analyses outside of institutional frameworks.
Background and Motivation
Yanowitz holds qualifications in electronics and physics, with professional experience in engineering and applied scientific instrumentation. Unlike many commentators on vaccine safety, he approached the subject through the lens of materials science and electronics, asking not "is this dangerous biologically?" but "what are the electromagnetic and conductive properties of this substance?"
His motivation to test vaccine vials reportedly came from exposure to the growing body of independent research suggesting that standard biological and pharmaceutical analysis was insufficient to characterise the full range of materials present in COVID-19 injections. Researchers like Dr. Pablo Campra at the University of Almería and the team at La Quinta Columna had already published findings they claimed identified graphene-family nanomaterials. Yanowitz sought to corroborate or refute these findings through a complementary methodology focused on electrical properties.
He has spoken publicly about his findings through independent media interviews and online video presentations, often in Hebrew with subtitles, making his work accessible to international audiences. His approach is notable for its emphasis on reproducibility — he describes his methods in sufficient detail that other researchers could, in principle, replicate them.
Methodology
Electrical Conductivity Testing
The central pillar of Yanowitz's research involves measuring the electrical conductivity of COVID-19 vaccine vial contents. This is not a standard pharmaceutical quality-control test. Legitimate vaccine formulations — containing proteins, lipids, saline buffers, polyethylene glycol (PEG), and mRNA or adenoviral vectors — should exhibit very low or negligible electrical conductivity. They are biological suspensions, not electronic materials.
Yanowitz designed simple but effective circuits to apply a low voltage across the contents of vaccine vials and measure current flow. A conductive reading — particularly one that increases with frequency in a manner consistent with semiconducting or metallic nanoparticulate material — would be considered anomalous in a pharmaceutical context.
His tests reportedly yielded measurable and in some cases significant conductivity readings, which he argues are inconsistent with the declared contents of the vials. He paid particular attention to how conductivity values varied across different vaccine brands and different batches.
Optical and Dark-Field Microscopy
In parallel with conductivity testing, Yanowitz employed optical microscopy and dark-field microscopy to examine the visual characteristics of vaccine samples. Dark-field microscopy illuminates particles using scattered light, making it effective for visualising nanoscale and microscale structures that would be invisible under conventional bright-field conditions.
His microscopy sessions were documented on video, showing what he described as unusual structures: fibrous formations, crystalline arrangements, and self-organising geometric patterns that appeared to emerge over time at room temperature. He drew parallels between these structures and those documented independently by Dr. Ana Maria Mihalcea, Mik Andersen, and researchers affiliated with Corona2Inspect.
Spectroscopic Considerations
While Yanowitz's primary toolkit was electrical and optical, he has also referenced the importance of Raman spectroscopy — a technique central to Dr. Pablo Campra's findings — for confirming the molecular identity of any graphene-family materials detected. He acknowledged that optical microscopy alone cannot definitively identify graphene but argued that the combination of conductivity anomalies and visual structure formation together constitute grounds for urgent further investigation using more advanced instrumentation.
Key Findings
Yanowitz's reported findings can be summarised as follows:
- Anomalous electrical conductivity in vaccine vial contents, inconsistent with the expected properties of lipid nanoparticles, mRNA, saline, or PEG-based formulations.
- Conductivity that increased with applied frequency, suggesting the presence of materials exhibiting frequency-dependent or resonant electronic behaviour — a characteristic associated with certain carbon-based nanomaterials including Graphene and graphene oxide.
- Microscopic structures visible under magnification that did not correspond to known lipid nanoparticle morphology, and which appeared to undergo spontaneous self-organisation over time — consistent with what other researchers have termed Self-Assembling Nanostructures.
- Batch variability: conductivity and structural observations were not uniform across all samples, suggesting either quality control inconsistencies or deliberate variation in formulation between batches — a finding echoed in the work of researchers analysing the so-called "hot lot" phenomenon in adverse event reporting.
- Absence of features consistent with pure mRNA lipid nanoparticle formulations: standard LNP (lipid nanoparticle) preparations do not self-organise, do not conduct electricity, and do not form crystalline structures at room temperature.
Yanowitz has been careful to frame his findings as raising questions rather than constituting final proof. He consistently calls for government laboratories and mainstream academic institutions to conduct independent testing using the same methods — a call that, he notes, has gone largely unanswered.
Relationship to Broader Independent Research
Yanowitz's work exists within a network of independent researchers whose collective findings, though arrived at through different methodological pathways, converge on similar conclusions.
- Dr. Pablo Campra (University of Almería, Spain) used Raman spectroscopy and transmission electron microscopy (TEM) to identify what he characterised as reduced graphene oxide structures in vaccine samples. His findings were published through Corona2Inspect, an independent scientific communication platform.
- La Quinta Columna, a Spanish research group led by Ricardo Delgado and Dr. José Luis Sevillano, were among the first to publicly claim graphene oxide presence in COVID vaccines and to articulate a hypothesis linking this to electromagnetic sensitivity and 5G infrastructure.
- Dr. Ana Maria Mihalcea, an American physician and researcher, has documented under live blood analysis and microscopy what she describes as self-assembling nanotechnology in both vaccinated and, more recently, unvaccinated individuals — potentially suggesting environmental or aerial transmission pathways.
- Mik Andersen (pseudonymous researcher, Corona2Inspect) has produced extensive technical analyses proposing that the observed structures conform to known designs for intra-body nano communication networks, including architectures referenced in scientific literature on Wireless Body Area Networks and IEEE 802.15.6 standards.
Yanowitz's conductivity findings provide a specific and testable dimension to this research web: if the materials identified visually by Campra and Andersen are genuinely present, they should produce exactly the kind of anomalous electrical signatures Yanowitz claims to have measured. The two lines of evidence are independently derived but mutually reinforcing.
Implications
Electrically Active Materials in Injectable Formulations
The significance of detecting electrically conductive or electronically active materials in injected substances extends well beyond conventional vaccine safety concerns. In the context of the Intra-Body Nano Network hypothesis — which proposes that nanoscale devices could theoretically be introduced into the human body to form a distributed sensor and communication network — electrical conductivity is not a side effect but a core functional requirement.
For such a network to operate:
- Individual nano-nodes must be capable of receiving and transmitting electromagnetic signals.
- Conductive pathways or materials must be present to enable energy harvesting from ambient electromagnetic fields or body heat.
- The network must be compatible with existing wireless communication standards — a role that IEEE 802.15.6, the standard governing Wireless Body Area Networks, has been proposed to fill.
If Yanowitz's conductivity measurements are accurate, they raise the question of whether injected formulations could be serving as delivery vehicles not just for immune-stimulating antigens, but for the foundational materials of such a network architecture — linking his work directly to the Transhumanist Agenda and the broader Biosurveillance framework being constructed under programmes such as Agenda 2030 and the Fourth Industrial Revolution.
Health Implications
Beyond the surveillance and control dimension, the presence of conductive nanomaterials in biological tissue raises independent toxicological and biophysical concerns. Graphene-family materials have well-documented cytotoxic profiles at certain concentrations. Electrically active materials in proximity to nerve tissue, cardiac muscle, or the blood-brain barrier present risks that are entirely outside the scope of conventional pharmaceutical safety evaluation frameworks.
Institutional Response and Suppression
Yanowitz's research, like that of his peers, has received no formal engagement from pharmaceutical manufacturers, national medicines regulators, or mainstream academic institutions. His videos and interviews have been subject to removal from major social media platforms, including YouTube, under policies targeting content that questions vaccine safety.
He has noted in interviews the profound absence of curiosity on the part of official bodies. Standard scientific practice — in the event that a credible researcher presents anomalous findings — would involve replication attempts, peer review invitations, or at minimum a formal rebuttal. None of these responses has been forthcoming from institutional science in relation to his work or that of his counterparts.
This silence is interpreted by Yanowitz and his associates not as dismissal on the grounds of scientific invalidity, but as a response consistent with the suppression of findings that, if confirmed, would have catastrophic implications for public health policy, regulatory credibility, and the broader agenda of technology-mediated human monitoring described in documents from the World Economic Forum and associated bodies.
The pathologisation of researchers who pursue this line of inquiry — through professional marginalisation, platform deplatforming, and occasional psychiatric dismissal — is itself a subject of ongoing documentation within the Targeted Individual and independent research communities.
